ヒュミラ治療薬の世界市場レポート 2025年

ヒュミラ治療薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で141億9,000万米ドルに成長します。予測期間の成長は、バイオシミラー市場への参入、ヘルスケア政策の変化、費用対効果の重視、研究開発投資、精密医療、個別化治療に起因すると考えられます。予測期間における主な動向としては、実臨床におけるエビデンスの創出、小児集団における使用の拡大、自己投与薬へのシフト、価値に基づく価格設定モデル、標的治療薬の開発などが挙げられます。

自己免疫疾患の罹患率の増加が予想されることから、ヒュミラ治療薬市場の今後の成長が期待されます。自己免疫疾患は、身体の免疫システムが誤って健康な組織や細胞を攻撃し、損傷することで発症します。ヒュミラは、さまざまな自己免疫疾患に伴う痛みや炎症を緩和するために使用されるため、これらの疾患の増加はヒュミラの需要増加につながります。例えば、米国を拠点とする非営利団体National Health Councilは2024年3月、自己免疫疾患は約5,000万人の米国人に影響を及ぼしていると報告しています。しかし、これらの疾患の診断は複雑であるため、この数字は過小評価されている可能性が高いです。憂慮すべきことに、自己免疫疾患の有病率は流行レベルに近づきつつあり、年間3～12％の増加を示す研究もあります。その結果、自己免疫疾患の罹患率が上昇し、ヒュミラ治療薬市場の成長に拍車がかかると思われます。

また、ヒュミラ治療薬市場は、さまざまな国や地域で承認された幅広い規制により、大きな成長を遂げています。世界各国の政府による規制の承認は、ヒュミラ治療薬の世界のアクセシビリティを高めています。例えば、2023年4月、欧州委員会は欧州連合（EU）において、バイオシミラーであるハイリモズ（アダリムマブ）のクエン酸塩を含まない高濃度製剤（HCF）の販売承認を与えました。ヒュミラに対する広範な規制当局の承認は、ヒュミラ治療薬市場の継続的成長に大きく寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界ヒュミラ治療薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界のヒュミラ治療薬市場：成長率分析
• 世界のヒュミラ治療薬市場の実績：規模と成長, 2019-2024
• 世界のヒュミラ治療薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界ヒュミラ治療薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のヒュミラ治療薬市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ヒュミラシリンジ
• ヒュミラペン
• 世界のヒュミラ治療薬市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 強直性脊椎炎
• 関節リウマチ
• クローン病
• その他の用途
• 世界のヒュミラ治療薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• その他のエンドユーザー
• 世界のヒュミラ治療薬市場、ヒュミラシリンジのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレフィルドシリンジ
• 使い捨て注射器
• 世界のヒュミラ治療薬市場、ヒュミラペンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 自動注射ペン
• プレフィルド注射ペン

第7章 地域別・国別分析

• 世界のヒュミラ治療薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のヒュミラ治療薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒュミラ治療薬市場：競合情勢
• ヒュミラ治療薬市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Sandoz International GmbH
• Hikma Pharmaceuticals PLC
• Celltrion Healthcare Co. Ltd.
• Cadila Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Mochida Pharmaceutical Co. Ltd.
• Innovent Biologics Inc.
• Biocad Biopharmaceutical Company
• Shanghai Henlius Biotech Inc.
• Glenmark Pharmaceuticals Ltd.
• Samsung Bioepis Co Ltd.
• Hetero Healthcare Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• ヒュミラ治療薬市場2029：新たな機会を提供する国
• ヒュミラ治療薬市場2029：新たな機会を提供するセグメント
• ヒュミラ治療薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Humira, or adalimumab, is an injectable medication prescribed for the treatment of rheumatoid arthritis and other related conditions. These drugs are utilized to alleviate pain and reduce swelling associated with various types of arthritis.

The primary forms of Humira drugs are Humira syringes and Humira pens. Humira syringes are a form of treatment specifically used for progressive rheumatoid arthritis. The diverse applications of Humira include treating conditions such as ankylosing spondylitis, rheumatoid arthritis, Crohn's disease, and others. These drugs are employed by various end-users, including hospitals, specialty clinics, and other healthcare facilities.

The humira drugs market research report is one of a series of new reports from The Business Research Company that provides humira drugs market statistics, including humira drugs industry global market size, regional shares, competitors with a humira drugs market share, detailed humira drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the humira drugs industry. This humira drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The humira drug market size has grown strongly in recent years. It will grow from $9.74 billion in 2024 to $10.43 billion in 2025 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to introduction of biologics, biotechnology advancements, patient demand for effective treatments, physician adoption and prescribing patterns

The humira drug market size is expected to see strong growth in the next few years. It will grow to $14.19 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to biosimilar market entry, healthcare policy changes, focus on cost-effectiveness, research and development investments, precision medicine and personalized treatments. Major trends in the forecast period include real-world evidence generation, expanded use in pediatric populations, shift towards self-administered medications, value-based pricing models, targeted therapies development.

An anticipated increase in the incidence rate of autoimmune diseases is expected to drive growth in the Humira drug market in the future. Autoimmune diseases occur when the body's immune system mistakenly attacks and damages healthy tissues and cells. Humira is utilized to alleviate pain and inflammation associated with various autoimmune conditions; thus, a rise in these diseases leads to increased demand for Humira. For example, in March 2024, the National Health Council, a U.S.-based non-profit organization, reported that autoimmune diseases affect approximately 50 million Americans. However, due to the complexities of diagnosing these diseases, this figure is likely underestimated. Alarmingly, the prevalence of autoimmunity is approaching epidemic levels, with some studies indicating an annual increase of 3-12%. Consequently, the rising incidence of autoimmune diseases will fuel the growth of the Humira drug market.

The humira drug market is also witnessing significant growth due to broad regulatory approvals granted across various countries and regions. Regulatory endorsements by governments worldwide enhance the accessibility of the humira drug globally. For instance, in April 2023, the European Commission granted marketing authorization for a citrate-free high concentration formulation (HCF) of the biosimilar Hyrimoz (adalimumab) in the European Union. The expansive regulatory approvals for Humira contribute significantly to the ongoing growth of the humira drug market.

Product innovation stands out as a key trend in the humira drug market, with major companies developing new biologics and biosimilars to maintain their market positions. In April 2023, Sandoz, a Switzerland-based pharmaceutical company, introduced the Biosimilar Hyrimoz (adalimumab), featuring a citrate-free high-concentration formulation (HCF) approved by the European Commission. This innovative formulation provides a 50% reduction in injection volume and offers an improved experience for patients with various diseases, including rheumatic diseases and Crohn's disease.

Major companies in the humira drug market are actively focusing on the development of biosimilars for humira drugs. This strategic approach aims to enhance the cost-effectiveness of humira drugs by producing specialty biosimilars tailored for these medications. In October 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched a biosimilar of Humira, approved by the US Food and Drug Administration as interchangeable with the original product, offering a more cost-effective alternative.

In August 2023, CVS Health Corporation, a US-based pharmacy company, entered into a partnership with Sandoz Group AG, a Switzerland-based pharmaceuticals company. This collaboration aims to create a nearly identical drug at a significantly lower cost than the popular arthritis treatment Humira. The partnership establishes Cordavis, a new subsidiary of Novartis, with a primary focus on ensuring the supply of novel biosimilar medications. This strategic move positions CVS Health to compete effectively in the biosimilars market, projected to reach $100 billion in sales over the next six years.

Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the humira drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The humira drug market consists of sales of single-dose pen, a single-dose prefilled syringe, and a single-dose vial of liquid solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Humira Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on humira drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for humira drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The humira drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Humira Syringe; Humira Pen
• 2) By Application: Ankylosing Spondylitis; Rheumatoid Arthritis; Crohn's Disease; Other Applications
• 3) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Subsegments:
• 1) By Humira Syringe: Pre-Filled Syringe; Disposable Syringe
• 2) By Humira Pen: Auto-Injector Pen; Pre-Filled Injection Pen
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Humira Drug Market Characteristics

3. Humira Drug Market Trends And Strategies

4. Humira Drug Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Humira Drug Growth Analysis And Strategic Analysis Framework

• 5.1. Global Humira Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Humira Drug Market Growth Rate Analysis
• 5.4. Global Humira Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Humira Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Humira Drug Total Addressable Market (TAM)

6. Humira Drug Market Segmentation

• 6.1. Global Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Humira Syringe
• Humira Pen
• 6.2. Global Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ankylosing Spondylitis
• Rheumatoid Arthritis
• Crohn's Disease
• Other Applications
• 6.3. Global Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users
• 6.4. Global Humira Drug Market, Sub-Segmentation Of Humira Syringe, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pre-Filled Syringe
• Disposable Syringe
• 6.5. Global Humira Drug Market, Sub-Segmentation Of Humira Pen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Auto-Injector Pen
• Pre-Filled Injection Pen

7. Humira Drug Market Regional And Country Analysis

• 7.1. Global Humira Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Humira Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Humira Drug Market

• 8.1. Asia-Pacific Humira Drug Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Humira Drug Market

• 9.1. China Humira Drug Market Overview
• 9.2. China Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Humira Drug Market

• 10.1. India Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Humira Drug Market

• 11.1. Japan Humira Drug Market Overview
• 11.2. Japan Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Humira Drug Market

• 12.1. Australia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Humira Drug Market

• 13.1. Indonesia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Humira Drug Market

• 14.1. South Korea Humira Drug Market Overview
• 14.2. South Korea Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Humira Drug Market

• 15.1. Western Europe Humira Drug Market Overview
• 15.2. Western Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Humira Drug Market

• 16.1. UK Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Humira Drug Market

• 17.1. Germany Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Humira Drug Market

• 18.1. France Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Humira Drug Market

• 19.1. Italy Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Humira Drug Market

• 20.1. Spain Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Humira Drug Market

• 21.1. Eastern Europe Humira Drug Market Overview
• 21.2. Eastern Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Humira Drug Market

• 22.1. Russia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Humira Drug Market

• 23.1. North America Humira Drug Market Overview
• 23.2. North America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Humira Drug Market

• 24.1. USA Humira Drug Market Overview
• 24.2. USA Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Humira Drug Market

• 25.1. Canada Humira Drug Market Overview
• 25.2. Canada Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Humira Drug Market

• 26.1. South America Humira Drug Market Overview
• 26.2. South America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Humira Drug Market

• 27.1. Brazil Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Humira Drug Market

• 28.1. Middle East Humira Drug Market Overview
• 28.2. Middle East Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Humira Drug Market

• 29.1. Africa Humira Drug Market Overview
• 29.2. Africa Humira Drug Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Humira Drug Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Humira Drug Market Competitive Landscape And Company Profiles

• 30.1. Humira Drug Market Competitive Landscape
• 30.2. Humira Drug Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis

31. Humira Drug Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Sandoz International GmbH
• 31.5. Hikma Pharmaceuticals PLC
• 31.6. Celltrion Healthcare Co. Ltd.
• 31.7. Cadila Pharmaceuticals Ltd.
• 31.8. Torrent Pharmaceuticals Ltd.
• 31.9. Mochida Pharmaceutical Co. Ltd.
• 31.10. Innovent Biologics Inc.
• 31.11. Biocad Biopharmaceutical Company
• 31.12. Shanghai Henlius Biotech Inc.
• 31.13. Glenmark Pharmaceuticals Ltd.
• 31.14. Samsung Bioepis Co Ltd.
• 31.15. Hetero Healthcare Ltd.

32. Global Humira Drug Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Humira Drug Market

34. Recent Developments In The Humira Drug Market

35. Humira Drug Market High Potential Countries, Segments and Strategies

• 35.1 Humira Drug Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Humira Drug Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Humira Drug Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer